Research supporting our approach

Our clinical program has been used since 2011 with over 50K patients in about 5000 clinics around the US and Canada to improve quality of life, symptoms of depression and anxiety and treatment adherence including hospitalization readmission and missed treatments. 

 
 
Screen Shot 2017-03-19 at 7.10.13 AM.png

STI Increases quality of life

The first study of STI in 2011 showed improvement in depression and quality of life scores.

There were  improvement in PCS and MCS (quality of life) scores of 51.6% and 61.3% of patients, respectively, and improvement in CES-D (depression) scores in 72.1% of patients.  These results were obtained when medical social workers spent 1.5 hours over six weeks with their patients to address symptoms of depression using STI techniques. 

 

STI decreases depression scores and improves lab values

STI was found to have a statistically significant improvement in patients’ CES-D 10 scores (p < 0.001) and in KDQOL-36 Mental Component scores (p < 0.001), Physical Component scores (p = 0.042), as well as Burden (p < 0.001) and Effects (p = 0.001) domain scores.  There were improvements in Albumin (p = 0.024) rates.

 
Screen Shot 2017-03-19 at 6.59.01 AM.png

STI Improves treatment adherence 

STI has been shown to decrease missed treatments by 34% in patients who miss 3+ treatments a month and to reduce hospitalization by 50%.